| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014742 Amide derivative |
| 01/19/2006 | US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 01/19/2006 | US20060014644 Phenylsulfonyl ureas, process for their preparation and their use as herbicides and plant growth regulators |
| 01/19/2006 | DE102004031323A1 Substituierte Pyridazincarboxamide und Derivate hiervon And derivatives thereof substituted Pyridazincarboxamide |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2573927A1 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 01/19/2006 | CA2571824A1 Mitotic kinesin inhibitors |
| 01/19/2006 | CA2571756A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571750A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571748A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/18/2006 | EP1616864A1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 01/18/2006 | EP1616576A1 Specific nad(p)h oxidase inhibitor |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615895A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 01/18/2006 | EP1615885A1 B -fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615637A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 01/18/2006 | EP1615633A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1417204B1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723043A 造影剂 Contrast agents |
| 01/18/2006 | CN1723021A Stable solid medicinal composition for oral administration. |
| 01/18/2006 | CN1721498A Fluorescent maleimides and uses thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1720913A Water-soluble triazole fungicide |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237054C Insecticidal and acaricidal agents |
| 01/17/2006 | US6987190 Reacting glyoxal and urea; sustained release fertilizer |
| 01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
| 01/17/2006 | US6987122 Antitumor agents; solid tumors of rectum, lungs |
| 01/17/2006 | US6987114 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987104 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 01/17/2006 | CA2229438C Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
| 01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
| 01/12/2006 | WO2006004925A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2006003378A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | WO2006003276A1 Substituted indazoles, compositions containing same, preparation and use |
| 01/12/2006 | WO2006003150A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006003146A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | WO2006002895A2 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases |
| 01/12/2006 | WO2005105079A3 Novel imidazoles |
| 01/12/2006 | WO2005103037A3 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | WO2005066175A3 Carbapenem intermediates and processes for their preparation |
| 01/12/2006 | WO2005060959A8 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 01/12/2006 | US20060009638 to silicon wafer; condensation of a carbon-substituted dipyrrolemethane with a dipyrromethane-1,9-dicarbinol then oxidation; substituents provide ability for high temperature attachment to silicon at two linkages |
| 01/12/2006 | US20060009626 Amidation or condensation of 2-aryl-3-alkoxycarbonyl-4-phenylhydrazone-5-pyrrolinones with a diamine or diol; paints |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009493 Indolinone hydrazides as c-Met inhibitors |
| 01/12/2006 | US20060009474 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 01/12/2006 | US20060009472 Substituted imidazole derivatives |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009460 e.g. N-(4-(4-methylpiperazin-1-yl)phenyl)-6-phenylquinolin-4-amine;protein kinase A, C, G, tyrosine kinase, mitogen activated p38- alpha kinase inhibitor; tumor necrosis factor- alpha and interleukin-1 beta antagonist; antiinflammatory, anticarcinogenic; Alzheimer's disease, stroke, diabetes, obesity |
| 01/12/2006 | US20060009459 Antidiabetic agents; disease of glucose tolerance; insulin resistance; obesity; dyslipidemia; metabolic disorders; liver disorders |
| 01/12/2006 | US20060009456 Aryl-substituted piperazine derivatives |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060009440 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570169A1 Azine-carboxamides as anti-cancer agent |
| 01/12/2006 | CA2569826A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2569824A1 Phthalazine derivatives as parp inhibitors |
| 01/12/2006 | CA2569679A1 Conjugates of antibody and duoarmycin derivatives as antitumor agents |
| 01/12/2006 | CA2568835A1 Quinazolinone derivatives as parp inhibitors |
| 01/12/2006 | CA2567744A1 Substituted indazoles, compositions containing same, preparation and use |
| 01/12/2006 | CA2564996A1 3-aryl-5,6-disubstituted pyridazines |
| 01/11/2006 | EP1614686A1 Bromide and its crystal |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613620A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/11/2006 | EP1613619A1 Quinazoline derivatives for treatment of cancer |
| 01/11/2006 | EP1613618A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 01/11/2006 | EP1613595A2 Novel compounds and compositions as protein kinase inhibitors |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 01/11/2006 | EP1613304A1 Dpp-iv inhibitors |
| 01/11/2006 | EP1491206A4 Induction method for cell differentiation |
| 01/11/2006 | CN1720245A Oxime ester photoinitiators with heteroaromatic groups |
| 01/11/2006 | CN1720236A 4-substituted benzimidazoles and their use as inhibitors of gastric secretion |